{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-25-009136","form_type":"8-K","ticker":"ZOMDF","cik":"0001684144","company_name":"Zomedica Corp.","filed_at":"2025-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.642595+00:00","generated_at":"2026-05-17T19:37:42.942146+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Zomedica Q2 revenue up 14% to $7M; Diagnostics segment jumps 86%","bullets":["Revenue $7.0M, up 14% YoY; gross margin 67%, consistent with prior period.","Diagnostics segment revenue $0.8M (+86%), driven by TRUFORMA platform adoption.","Net loss $7.4M vs $23.9M (including $16M impairment) in Q2 2024; Adj. EBITDA loss $5.5M.","Operating expenses down $0.7M excluding impairment; liquidity $59.1M.","Record 18th consecutive quarter of YoY revenue growth; consumable sales up 21%."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-25-009136","json":"https://secwatch.observer/filing/0001654954-25-009136.json","markdown":"https://secwatch.observer/filing/0001654954-25-009136.md","text":"https://secwatch.observer/filing/0001654954-25-009136.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1684144/000165495425009136/0001654954-25-009136-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1684144/000165495425009136/zom_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T19:37:42.942146+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}